Mounjaro® 40mg [10mg/0.6mL – 2.4mL] multi-dose KwikPen® (tirzepatide Injection Pen) – Lilly

Description

MOUNJARO® (TIRZEPATIDE) 10MG/0.6ML – 2.4ML MULTI-DOSE KWIKPEN® – LILLY
Delivers 4 x 10MG Doses per Pen

The Mounjaro® KwikPen® by Lilly contains 40 mg’s of Tirzepatide 10MG/0.6ML in a 2.4ML multi-dose injection pen, providing four precision-dosed 10MG injections per pen. Tirzepatide is a powerful dual GIP and GLP-1 receptor agonist that’s reshaping the landscape of fat loss, metabolic enhancement, and appetite control.

Ideal for advanced body recomposition and metabolic support, Mounjaro® helps users achieve significant reductions in body weight, while improving insulin sensitivity, glucose stability, and hormonal regulation. It’s a premier choice for those pursuing peak performance, longevity, and transformative body change.

Crafted by Eli Lilly, this FDA-approved, research-backed therapeutic delivers reliable, pharmaceutical-grade performance in a convenient KwikPen® format, eliminating the need for reconstitution or vials.

For more elite peptide therapies and injectable solutions, visit: True North Performance